BridgeMD
New treatment option for Social Anxiety Disorder (Social Phobia)
Official title Reward Processing and Exposure Therapy for Social Anxiety Disorder
ClinicalTrials.gov ID: NCT06776991
What this study is testing
- What it's testing
- The investigators are conducting a clinical trial of therapy for public speaking anxiety. There are many eligibility criteria, but the main ones are that participants need to be socially anxious and have public speaking anxiety.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60
You may be able to join if
- Diagnosis of social anxiety disorder from the Structural Clinical Interview for DSM 5.
- Elevated fear of public speaking, defined as a score of \>= 66 (+1SD from the mean of population norms on a scale of 17-85) on the Public Speaking...
- Low reward processing, defined as a score of \<56 (less than the population mean) on the Dimensional Anhedonia Rating Scale (DARS) (Rizvi, S. J...
- Medication-free or stabilized on psychotropic medications for a minimum standard length of time (1 month for benzodiazepines and beta blockers, 3...
- Psychotherapy-free or stabilized on alternative psychotherapies other than cognitive or behavioral therapies that were not focused on their anxiety...
You likely can't join if
- (none of the following):
- Recent suicidal ideation with intent or plan - defined as suicidal ideation with intent or plan in the past year.
- Lifetime history of suicide attempts.
- History of bipolar disorder, psychosis, intellectual disability, or organic brain damage.
- Substance use disorder within the last 6 months.
- Major respiratory, cardiovascular, pulmonary, neurological, or muscular-skeletal diseases.
See the full eligibility criteria
- Diagnosis of social anxiety disorder from the Structural Clinical Interview for DSM 5.
- Elevated fear of public speaking, defined as a score of \>= 66 (+1SD from the mean of population norms on a scale of 17-85) on the Public Speaking Anxiety Scale (PSAS; Bartholomay, E. M., \& Houlihan, D. D. (2016)...
- Low reward processing, defined as a score of \<56 (less than the population mean) on the Dimensional Anhedonia Rating Scale (DARS) (Rizvi, S. J., Quilty, L. C., Sproule, B. A., Cyriac, A., Bagby, R. M., \& Kennedy, S...
- Medication-free or stabilized on psychotropic medications for a minimum standard length of time (1 month for benzodiazepines and beta blockers, 3 months for SRIs/SNRIs and heterocyclics).
- Psychotherapy-free or stabilized on alternative psychotherapies other than cognitive or behavioral therapies that were not focused on their anxiety disorder for at least 6 months prior to study entry.
- Age 18-60.
- Fluent in English.
- To conduct MRI version of fear conditioning task, must have no MRI contraindications.
- (none of the following):
- Recent suicidal ideation with intent or plan - defined as suicidal ideation with intent or plan in the past year.
- Lifetime history of suicide attempts.
- History of bipolar disorder, psychosis, intellectual disability, or organic brain damage.
- Substance use disorder within the last 6 months.
- Major respiratory, cardiovascular, pulmonary, neurological, or muscular-skeletal diseases.
- Pregnant or planning to become pregnant for next 6 months.
The study team makes the final eligibility decision.
Where it's taking place
- Los Angeles, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Los Angeles, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.